AI assistant
Sending…
Eton Pharmaceuticals, Inc. — Director's Dealing 2021
Feb 16, 2021
32663_dirs_2021-02-16_bf5f2ca3-c83b-4208-9850-e3863bc86c05.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: Eton Pharmaceuticals, Inc. (ETON)
CIK: 0001710340
Period of Report: 2020-12-31
Reporting Person: CASAMENTO CHARLES J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-19 | Common Stock | G | 3500 | $0.00 | Disposed | 68420 | Direct |
More from Eton Pharmaceuticals, Inc.
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 16
Annual Report
2026
Mar 19
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 25
Director's Dealing
2026
Feb 5